Also available in Persian — نسخه فارسی ✈️ Telegram EN فا
❓ Unknown

WHO Organizes Virtual Workshops on Good Manufacturing Practices for Pharmaceutical Units

2w ago October 15, 2026 1 min read 📰 WHO News
📋 Key Takeaway

The WHO, in collaboration with JSS AHER and the Indian Pharmaceutical Alliance, has organized virtual workshops on Good Manufacturing Practices (cGMP) to enhance pharmaceutical manufacturing capabilities in SMEs. This initiative aims to improve the quality and accessibility of medical products, which could have implications for Iran's pharmaceutical sector.

🔍 Quick Context Guide
💡 Bottom Line: The WHO's workshops aim to elevate pharmaceutical standards in India, which could have positive ripple effects in Iran's healthcare system.

👥 Key Players

World Health Organization (WHO) MENTIONED
Global health authority
"The WHO plays a crucial role in setting health standards and guidelines, which can influence health policies in Iran."
JSS Academy of Higher Education & Research MENTIONED
Educational institution
"Contributes expertise in pharmaceutical education and practices, impacting the quality of healthcare in Iran."
Indian Pharmaceutical Alliance (IPA) MENTIONED
Industry association
"Represents the interests of pharmaceutical companies, which can provide models for Iran's pharmaceutical industry."
Indian Ministry of Health MENTIONED
Government authority
"Regulates health policies in India, which can serve as a reference for Iranian health policy development."

📰 What Happened

The WHO, along with JSS AHER and the IPA, organized virtual workshops to enhance Good Manufacturing Practices (cGMP) for small and medium pharmaceutical enterprises in India. This initiative aims to improve the quality and accessibility of medical products.

  • The workshops are the first of their kind organized by WHO at multiple levels.
  • The initiative focuses on strengthening the pharmaceutical manufacturing capabilities in SMEs.

💡 Why It Matters

🇮🇷 For Iran: Improving manufacturing practices in Iran's pharmaceutical sector could enhance the quality of medical products available to its population.
🌍 Regional: Strengthening pharmaceutical practices in India may set a precedent for neighboring countries, including Iran, to follow.
🌐 International: Internationally, this initiative reflects a growing emphasis on quality in pharmaceutical manufacturing, which is crucial for global health security.

📚 Background

Good Manufacturing Practices (cGMP) are essential for ensuring the quality and safety of pharmaceutical products. Many countries, including Iran, are working to improve their manufacturing standards.

Pharmaceutical regulations Global health initiatives
📡 Source: NEUTRAL
📊 Confidence: 70%
The information comes from a reputable international health organization, suggesting a focus on factual reporting.

A first of its kind, Virtual Workshops on Good Manufacturing Practices (cGMP) have been organized and implemented by all three levels of WHO (Country Office, Regional Office, Headquarters) in collaboration with JSS Academy of Higher Education & Research (JSS AHER), Mysuru, Indian Pharmaceutical Alliance (IPA) under the guidance of Indian Ministry of Health. The activity aimed to strengthen the capacities of pharmaceutical manufacturing in the small and medium enterprises (SMEs) in the country and share global practices to promote availability and access to quality medical products.Please click here to access this article which was initially published on our regional web site.  

🌐

Translated from the original and edited for English readers. View original source →

Translation confidence: 100%

📰 Related Coverage

⚖️ Independent Platform — Artesh.com is not affiliated with any government, military, or political organization. Editorial Policy →